Live news related to ABIVAX stock (FR0012333284): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The French biotech company experiences another session in the red, extending a downward trend that has been in place for several weeks. The stock is m…
The French biotech faces another tough session at close, erasing the rebound sketched the previous day. The stock is among the biggest losers in the b…
The French biotech firm shows signs of recovery at the opening, after several weeks of significant decline. The stock climbs to the top of the broad P…
The French biotech company falls during the session and sinks to the bottom of the broad Parisian index. The stock extends a decline that began severa…
The French biotech takes a breather after a sharp rebound in previous sessions. The stock is part of a declining Parisian market, amid a resurgence of…
French biotech Abivax recovers in the trading session, climbing 8.16% to €90.80 and taking the lead in the SBF 120 index. The stock regains the top sp…
The French biotech continues its recovery from yesterday after the sharp drop following the phase 3 results of obefazimod. The stock leads the SBF 120…
The French biotech regains ground after a bleak session that saw its share price plummet by about 31%. The stock is attempting a technical stabilizati…
The French biotech faces a sharp setback the day after the phase 3 results of its flagship drug candidate in ulcerative colitis. The market heavily pe…
Abivax announced on Monday positive results from the phase 3 ABTECT maintenance trial evaluating obefazimod in active moderate to severe ulcerative co…
